Cart
sales@molnova.com
NLG802
CAS No. 2071683-99-1
NLG802( —— )
Catalog No. M35122 CAS No. 2071683-99-1
NLG802 is a prodrug of indoximod, serving as an orally active inhibitor of indoleamine 2,3-dioxygenase (IDO).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | In Stock |
|
| 5MG | 56 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 169 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNLG802
-
NoteResearch use only, not for human use.
-
Brief DescriptionNLG802 is a prodrug of indoximod, serving as an orally active inhibitor of indoleamine 2,3-dioxygenase (IDO).
-
DescriptionNLG802 is a proagent of indoximod, an orally active indoleamine 2,3-dioxygenase (IDO) inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetIDO
-
RecptorIndoleamine 2,3-Dioxygenase (IDO)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2071683-99-1
-
Formula Weight395.92
-
Molecular FormulaC20H30ClN3O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (631.44 mM; Ultrasonic )
-
SMILESCl.CCOC(=O)[C@@H](Cc1cn(C)c2ccccc12)NC(=O)[C@@H](N)CC(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kumar S, et al. Discovery of indoximod prodrugs and characterization of clinical candidate NLG802. Eur J Med Chem. 2020 Jul 15;198:112373. ?
molnova catalog
related products
-
Flemiphilippinin D
Kushenol E is a class of flavonoids isolated from Sophora flavescens. It is a non-competitive IDO1 inhibitor (IC50: 7.7?μM Ki: 9.5?μM) has anti-tumor activity.
-
IDO-IN-1
IDO-IN-1 is a potent indoleamine 23-dioxygenase (IDO) inhibitor( IC50 values of 59 and 12 nM for human IDO enzymatic activity and HeLa cell assays respectively.)
-
Epacadostat
Epacadostat, also known as INCB024360 or INCB24360, is an orally available hydroxyamidine and inhibitor of indoleamine 2,3-dioxygenase (IDO1), with potential immunomodulating and antineoplastic activities.
